semaglutide hfpef trial improves heart failure-related symptoms and physical function and results in greater weight loss compared with placebo in patients with # and #obesity ⬇️ #ESCCongress STEP-HFpEF VisualAbstract: Semaglutide improves symptoms in

If fatigue , medication tolerance , or persistent GI distress has made pharmaceutical GLP-1 drugs unworkable, a probiotic approach offers a fundamentally different mechanism with a much milder side effect profile

Marino D, Dunand C, Puppo A, Pauly N

Post-infection levels were 21% higher in cystine-fed animals, although this increase did not reach statistical significance

The dose escalation timeline and why it matters for results The standard semaglutide dose escalation for weight management follows a specific schedule

After a review of the totality of information, including all clinical data generated to date for danuglipron and recent input from regulators, Pfizer has decided to discontinue development of the molecule

Naunyn Schmiedebergs Arch Pharmacol 388:905919